Title of article
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
Author/Authors
Christian Jaggy، نويسنده , , Jan von Overbeck، نويسنده , , Bruno Ledergerber، نويسنده , , Claude Schwarz، نويسنده , , Matthias Egger، نويسنده , , Martin Rickenbach، نويسنده , , Hansjakob Furrer، نويسنده , , Amalio Telenti and for the Swiss HIV Cohort Study، نويسنده , , Manuel Battegay، نويسنده , , Markus Flepp، نويسنده , , Pietro Vernazza، نويسنده , , Enos Bernasconi، نويسنده , , Bernard Hirschel and the Swiss HIV Cohort Study، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2003
Pages
2
From page
877
To page
878
Abstract
Because of high death rates in the past, patients with HIV-1 cannot obtain life insurance. We measured mortality rates in the Swiss HIV Cohort Study (SHCS) from 1997 to 2001 and compared them with those of the Swiss reference population. In patients who were successfully treated with highly active anti-retroviral therapy (HAART), and who were not also infected with the hepatitis C virus, excess death rates were below five per thousand per year. Patients with successfully treated cancer have much the same excess death rates but are not excluded from life insurance policies.
Journal title
The Lancet
Serial Year
2003
Journal title
The Lancet
Record number
559603
Link To Document